<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03806205</url>
  </required_header>
  <id_info>
    <org_study_id>PekingUPHmed</org_study_id>
    <nct_id>NCT03806205</nct_id>
  </id_info>
  <brief_title>Efficacy Management and Adherence Evaluation of Diclofenac in the Treatment of Knee Osteoarthritis Pain</brief_title>
  <official_title>Efficacy Management and Adherence Evaluation of Diclofenac in the Treatment of Knee Osteoarthritis Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University People's Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the effect of dichloride on pain control of knee osteoarthritis and the
      relationship between pain relief and medicine adherence. To evaluate the pain relief rate of
      patients with different initial pain.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 15, 2019</start_date>
  <completion_date type="Anticipated">March 15, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 10, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>adherence</measure>
    <time_frame>6-8 weeks</time_frame>
    <description>We will calculate adherence with medication use</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pain relief rate</measure>
    <time_frame>6-8 weeks</time_frame>
    <description>We will calculate the pain relief rate on all participants</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>womac score</measure>
    <time_frame>6-8 weeks</time_frame>
    <description>We will calculate the womac score on all participants</description>
  </secondary_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>To Investigate the Effect of Diclofenac on Pain Control of Knee Osteoarthritis and the Relationship Between Pain Relief and Medicine Adherence</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>regular follow-up</intervention_name>
    <description>we give a regular follow-up and supervision on the study group</description>
    <other_name>supervision</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  According to the OA diagnostic criteria of knee joint, the side with higher WOMAC
             score is defined as observing knee joint for patients with both knees conforming to OA
             diagnostic criteria.

               1. Repeated knee pain in the past month

               2. X-ray showed narrowing of articular space, subchondral sclerosis and/or cystic
                  degeneration, and formation of osteophyte at articular margin.

               3. Joint fluid (&gt; 2 times) is cool and sticky, WBC &lt; 2000/ml

               4. Age over 40

               5. Morning stiffness less than 30 minutes

               6. Bone fricative (sensation) during exercise According to 1+2 or 1+3+5+6 or
                  1+4+5+6, OA of knee joint can be diagnosed.

               7. The informed consent has been signed

        Exclusion Criteria:

          -  (1) Joint pain caused by other causes (infection, hip, lumbar and other diseases) (2)
             Secondary arthritis (rheumatoid arthritis, ankylosing spondylitis, etc.) (3) Severe
             internal medical complications and other inability to participate in the research (4)
             Pain in other parts exceeds joint pain (5) Contraindications to diclofenac use: active
             peptic ulcer/allergy/induced asthma (6) Assessment may not complete the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jianhao Lin, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Peking University People's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yudian Qiu, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Peking University People's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yudian Qiu, M.D.</last_name>
    <phone>+8613381150519</phone>
    <email>1210301417@pku.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jianhao Lin, M.D.</last_name>
    <email>linjianhao@pkuph.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peking University People's Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Xicheng District</state>
        <zip>100044</zip>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Yudian Qiu, M.D.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>da Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, JÃ¼ni P, Trelle S. RETRACTED: Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet. 2016 May 21;387(10033):2093-2105. doi: 10.1016/S0140-6736(16)30002-2. Epub 2016 Mar 18. Retraction in: Lancet. 2017 Jul 8;390(10090):109. Corrected and republished in: Lancet. 2017 Jul 8;390(10090):e21-e33.</citation>
    <PMID>26997557</PMID>
  </reference>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>January 14, 2019</study_first_submitted>
  <study_first_submitted_qc>January 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 16, 2019</study_first_posted>
  <last_update_submitted>January 14, 2019</last_update_submitted>
  <last_update_submitted_qc>January 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Knee osteoarthritis pain; Adherence; Diclofenac; Follow up</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

